September 26, 2013
FPMAJ Chairman Haruo Naito Three major pharmaceutical trade groups reiterated their calls for the full and permanent introduction of the premium for new drug development at a Central Social Insurance Medical Council (CSIMC) subcommittee meeting on September 25, but they...read more